Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: An open-label study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 3, 2008, Pages 761-764

  Miyaoka, Tsuyoshi ^a   Furuya, Motohide ^a   Yasuda, Hideaki ^a   Hayashida, Maiko ^a   Nishida, Akira ^a   Inagaki, Takuji ^a   Horiguchi, Jun ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

5 HT2A antagonism; Schizophrenia; Tardive dyskinesia; Yi gan san

Indexed keywords

HERBACEOUS AGENT; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; UNCLASSIFIED DRUG; YI GAN SAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; NAUSEA; OPEN STUDY; SCHIZOPHRENIA; TARDIVE DYSKINESIA; UNSPECIFIED SIDE EFFECT;

EID: 39749155223     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.12.003     Document Type: Article

References (20)

1. Aizawa R. Kanbayashi T. Saito Y. Ogawa Y. Sugiyama T. Kaneko T. Effects of yoku-kan-san-ka-chipi-hange on the sleep of normal healthy adult subjects Psychiatry Clin Neurosci 56 2002 303 304
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders Fourth Edition 1994 American Psychiatric Association Washington, DC
3. Barnett A.G. van der Pols J.C. Dobson A.J. Regression to the mean: what it is and how to deal with it Int J Epidemiol 34 2005 215 220
4. Bartko J.J. Carpenter W.T. On the methods and theory of reliability J Nerv Ment Dis 163 1976 307 317
5. Chouinard G. Annable L. Ross-Chouinard A. Mercier P. A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases J Clin Psychopharmacol 8 Aug suppl 1988 21S 26S
6. Egan M.F. Apud J. Wyatt R.J. Treatment of tardive dyskinesia Schizophr Bull 23 1997 583 609
7. Furuya M. Kunishige K. Horiguchi J. Three case of Lewy body disease with hallucination successfully treated with yi-gan san Seishin Igaku 49 2007 417 420 (in Japanese)
8. Goldman D. Treatment of phenothiazine-induced dyskinesia Psychopharmacol Bull 12 1976 7 10
9. Guy W. ECDEU Assessment Manual for Psychopharmacogy-Revised, Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs 1976 218 222
10. Guy W. ECDEU Assessment Manual for Psychopharmacogy-Revised, Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs 1976 534 537
11. Ichikawa J. Dai J. Meltzer H.Y. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release Brain Res 907 2001 151 155
12. Ishibashi A. Egashira N. Mishima K. Iwasaki K. Fujiwara M. Study on the central action of Yoku-kan-san Yakugaku Zasshi 126 sup 2 2006 82 84 (Abstract in English)
13. Iwasaki K. Satoh-Nakagawa T. Maruyama M. A randomized observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients J Clin Psychiatry 66 2005 248 252
14. Kay S.R. Fiszbein A. Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 13 1987 261 276
15. Liao J.F. Jan Y.M. Huang S.Y. Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs Proc Natl Sci Counc Repub China B 19 1995 151 158
16. Lieberman J.A. Understanding the mechanism of action of atypical antipsychotic drug: a review of components in use and developments Br J Psychiatry 163 suppl 12 1993 7 18
17. Miyaoka T. Furuya M. Yasuda H. Hayashida M. Inagaki T. Horiguchi J. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: An open-label study Prog Neuro-Psychopharmacol & Biol Psychiat 32 2008 761 764
18. Seibyl J.P. Glazer W.M. Innis P.B. Serotonin function in tardive dyskinesia Psychiatr Ann 19 1989 310 314
19. Shimada Y. Goto H. Itoh T. Evaluation of the protective effects of alkaloids isolated from the hooks and stems of Uncaria sinesis on glutamate-induced neuronal death in cultured cerebellar granule cells from rats J Pharm Pharmcol 51 1999 715 722
20. Stockmeier C.A. DiCarlo J.J. Zhanng Y. Thompson P. Meltzer H.Y. Characterization of typical and atypical antipsychotic drugs based on in-vivo occupancy of serotonin2 and dopamine2 receptors J Pharmacol Exp Ther 266 1993 1374 1384